Media Coverage
HRV Pharma Honoured at ET RE-Pharma Awards 2026 for Excellence in Pharma Global Business Support
HRV Pharma (Group) has been recognised at the ET RE-Pharma Awards 2026 for Excellence in Pharma Global Business Support, highlighting its leadership in compliant, agile, and globally integrated pharmaceutical operations.
Why API Self-Reliance Is Back at the Centre of India’s Pharma Strategy
In BW Healthcare World, HRV Pharma MD & CEO Hari Kiran Chereddi outlines why API self-reliance has re-emerged as a strategic priority under Biopharma SHAKTI and what it means for India’s pharmaceutical future.
Union Budget 2026–27: Strengthening India’s Biopharma Ecosystem and Healthcare Access
HRV Pharma CEO Hari Kiran Chereddi shares his insights on how Union Budget 2026–27’s focus on biopharma innovation, affordable cancer care, and healthcare infrastructure will shape India’s pharmaceutical future.
HRV Pharma Partners with Haleos Labs to Accelerate Orphan and Niche API Development
HRV Pharma has entered a multi‑year strategic partnership with Haleos Labs to accelerate the development and manufacture of orphan and niche APIs, strengthening global access to complex therapies for rare diseases.
How HRV Pharma’s Virtual Model Helps Solve America’s Drug Shortage Crisis
HRV Pharma’s capital‑efficient virtual pharmaceutical model is helping address America’s drug shortage crisis by linking underutilized global manufacturing capacity with regulatory strength to ensure consistent API supply.
HRV Pharma Redefines India’s Bulk Drug Business with a Virtual Pharma Model
Fortune India features HRV Pharma for pioneering a capital‑efficient virtual pharma model that is transforming India’s bulk drug and API ecosystem through speed, compliance, and global regulatory execution.
Indian Biosimilars on the Global Stage: HRV Pharma CEO's Insights in Express Pharma
India's rise in biosimilars & biologics. Full clipping + insights included.
HRV Pharma Earns Great Place To Work® Certification for 2025–2026
HRV Pharma has been officially certified as a Great Place To Work® for 2025–2026, with multiple media outlets highlighting the company’s culture of trust, inclusivity, and employee empowerment.
GLP-1 Patents Are Fading - Can India Become the GLP-1 Generics Powerhouse
As GLP-1 patents expire, India’s manufacturing scale, peptide chemistry expertise, and compliance readiness could position it to supply affordable GLP-1 generics globally — but consistency and supply reliability will decide who wins
HRV Pharma and Metrochem Strategic CDMO Alliance for High-Value NCE-1 APIs
HRV Pharma and Metrochem API Pvt. Ltd. have formed a multi-year CDMO alliance to accelerate high-value NCE-1 API development, combining Virtual Pharma innovation with world-class GMP chemistry
AI Is Redefining Pharma Forecasting and Eliminating the Compliance Trade-Off
Pharmaceutical Commerce features HRV Pharma on how AI-validated digital backbones speed regulatory reviews, improve supplier onboarding, and make forecasting more reliable.
Can AI Make Pharma Supply Chains Truly Unbreakable?
HRV Pharma's CEO discusses how AI transforms pharmaceutical supply chains from reactive systems to anticipatory networks, ensuring continuous medicine availability through predictive intelligence.
Rethinking Pharma Supply Chains: Building Resilience With Digital Intelligence
HRV Pharma's CEO Hari Kiran Chereddi explores how digital intelligence and AI are transforming pharmaceutical supply chains from efficiency-driven models to resilient, adaptive networks.
Indian API Makers Gear Up for Semaglutide Demand
HRV Pharma's CEO discusses Indian API manufacturers' strategic preparation for semaglutide demand as Ozempic patent expiry approaches, with extensive global media coverage.
Building Resilient Pharmaceutical Supply Chains in an Era of Disruption
HRV Pharma's MD & CEO Hari Kiran Chereddi discusses strategic approaches to pharmaceutical supply chain resilience, highlighting multi-partner networks and AI-native operations for industry transformation.
From Pharmacy to Intelligent Pharmacy: AI's Role in India's Pharma Evolution
HRV Pharma's CEO Hari Kiran Chereddi discusses how AI is transforming India from the traditional "pharmacy of the world" into the "intelligent pharmacy of the world," revolutionizing drug discovery, regulatory processes, and supply chain management
From Volume to Value: India's Strategic API Leadership Evolution
HRV Global's Managing Director Hari Kiran Chereddi discusses India's transformation from volume-driven API supplier to value-oriented strategic partner, highlighting virtual pharma models and AI-driven operations.
US Tariffs Threaten Indian Pharma Exports-Urgent Need for Diversification and Policy Support
Our leadership analyzes impact of US 50% tariffs on Indian pharmaceutical exports, highlighting challenges for SMEs and strategic responses including market diversification.
India's Pharma Industry Goes Global: From Generics to Innovation Leadership
HRV Pharma's CEO Hari Kiran Chereddi analyzes India's pharmaceutical transformation from affordable generics manufacturer to global hub of compliance, innovation, and supply chain excellence.
GLP-1 Patent Expiry 2026: A Defining Opportunity for Indian Pharma
HRV Pharma's CEO Hari Kiran Chereddi analyzes India's strategic opportunity in GLP-1 drug manufacturing as Semaglutide patents expire in 2026, emphasizing the shift from reverse engineering to innovative design.
The US Drug Pricing Shock: A Mandate for Recalibration, Not Reaction
HRV Pharma's CEO Hari Kiran Chereddi outlines strategic recalibration approach to US drug pricing policies, emphasizing global diversification and value-based transformation over reactive market responses.
Express Pharma June 2025 Feature : The New Rules of Pharma
HRV Pharma is redefining pharmaceutical manufacturing through distributed orchestration, compliance-driven models, and technology-first strategies to build resilient, globally connected supply chains for the future.
Life Sciences Sector Maximizes Advanced Technology Adoption
HRV Pharma's leadership shares insights on National Technology Day 2025, highlighting how AI, machine learning, and digital technologies are revolutionizing healthcare delivery and pharmaceutical innovation
Trump's MFN Executive Order Strengthens Generic and Biosimilar Adoption
Analysis of President Trump's Most Favored Nation executive order impact on generic and biosimilar markets, with HRV Pharma's strategic insights on opportunities for Indian pharmaceutical manufacturers
India's Strategic Role in the Global Medtech Reset: Navigating US Tariffs
Our CEO Hari Kiran Chereddi shares insights in Citeline Medtech Insight on India's role in global supply chains amidst US medical device tariffs.
Green Pharma 2.0: AI and Digital Twins Revolutionizing Indian Pharmaceutical Manufacturing
HRV pharma's Hari Kiran Chereddi discusses AI, digital twins, and sustainable molecule design transforming Indian pharmaceutical manufacturing.
US Tariff Relief for Indian Pharma: A Strategic Opportunity for Growth?
Discover how Indian pharma can leverage US tariff relief to strengthen partnerships, innovate, and maintain global competitiveness in healthcare affordability.
HRV Pharma Facilitates Historic First Shipment of Indian Anti-Diabetic Drugs to Argentina
In a significant milestone for India-Argentina healthcare cooperation, HRV Pharma has successfully delivered the first consignment of USFDA-qualified Metformin to Mendoza province, achieving estimated savings of 45-50% for patients.
HRV Pharma Strengthens Global Presence at DCAT Week 2025 in New York
HRV Pharma makes significant strides in global pharmaceutical partnerships during DCAT Week 2025 in New York, showcasing innovation and expanding its international footprint.
How Indian Pharma is Preparing to Mitigate US Tariff Challenges
HRV Pharma's leadership discusses strategic approaches for Indian pharmaceutical companies to navigate potential US tariff challenges while maintaining global competitiveness and healthcare affordability.
Pharma Leveraging AI: Transforming the Future of Drug Development
The pharmaceutical industry is undergoing a revolution, powered by Artificial Intelligence (AI). As highlighted in a recent article, AI is transforming drug discovery, clinical trials, disease diagnosis, and manufacturing processes.
Indian Pharma's Strategic US Expansion: Insights from Hari Kiran Chereddi
Hari Kiran Chereddi shares strategic insights on Indian pharma’s US expansion via acquisitions, regulatory agility, and supply chain resilience in a competitive market.
HRV Pharma Showcases Virtual Manufacturing Innovation at Industry Conference
CEO Hari Kiran Chereddi highlights HRV’s virtual manufacturing model, blending AI and blockchain to redefine pharma production and global market access.
Union Budget 2025-26: A Transformative Leap for India’s Healthcare Sector
Our CEO Mr. Hari Chereddi, applauds the government's decision to exempt Basic Customs Duty on 36 life-saving drugs, highlighting the positive impact on patient accessibility and affordability
HRV Pharma Eyes Strategic Expansion into Sri Lankan Pharmaceutical Market
HRV Pharma has announced its strategic interest in expanding operations into Sri Lanka, positioning the island nation as a key growth market in the company's South Asian expansion strategy.
Hari Kiran Chereddi Featured in Exclusive CPhI Milan Interview
HRV’s CEO discusses virtual pharma models and navigating complex global markets in a CPhI Milan interview, emphasizing innovation and regulatory mastery.
CNN Business Arabic has featured HRV Global Life Sciences
CNN Business Arabic highlights HRV Global's resilient supply chain strategies and ambitious Middle East expansion plans, showcasing success in complex markets including Iran, Iraq, and UAE.
HRV Pharma Honored with Dual Leadership Awards for Excellence in India and Middle East Markets
HRV Pharma has been honored with two prestigious leadership awards, recognizing the company as a leading pharmaceutical enterprise in both India and the Middle East markets